ENIGMA联盟精神分裂症患者皮质脑异常的大样本荟萃分析
本研究由ENIGMA精神分裂症工作组开展,纳入4474例精神分裂症患者与5098名健康对照的标准化结构MRI数据,发现患者存在广泛的皮质变薄和表面积减小,额叶与颞叶效应量最大,且皮质厚度效应与抗精神病药物使用相关。
要点
- 精神分裂症患者皮质厚度和表面积均较健康对照减小,额叶与颞叶效应量最大。
- 皮质厚度组间差异在控制全脑皮质厚度后仍显著,提示区域特异性。
- 接受抗精神病药物治疗者皮质厚度效应量较未用药者大2至3倍。
核心结论
- 精神分裂症患者存在广泛的皮质变薄和表面积减小,额叶与颞叶效应量最大。
- 皮质厚度区域差异具有特异性,而表面积效应呈全局性。
- 抗精神病药物使用与更大的皮质厚度效应量相关,未来遗传关联研究需考虑药物影响。
研究设计与样本
- ENIGMA精神分裂症工作组开展的首项皮质厚度与表面积荟萃分析。
- 纳入4474例精神分裂症患者(平均年龄32.3岁,范围11-78岁,66%男性)和5098名健康志愿者(平均年龄32.8岁,范围10-87岁,53%男性)。
- 数据来自全球39个中心,采用标准化方法评估。
主要发现
- 与健康志愿者相比,患者皮质更薄(左/右半球Cohen's d = -0.530/-0.516),表面积更小(左/右半球Cohen's d = -0.251/-0.254)。
- 皮质厚度和表面积的最大效应量均位于额叶和颞叶区域。
- 控制全脑皮质厚度后,区域皮质厚度组间差异仍显著,提示区域特异性;表面积效应则呈全局性。
- 接受抗精神病药物治疗者的皮质厚度负性效应量是未用药者的2至3倍。
- 患者双侧颞极厚度与年龄的负相关强于健康志愿者;区域皮质厚度与归一化药物剂量、症状严重程度和病程呈显著负相关,与发病年龄呈正相关。
临床怎么用
- 精神分裂症患者的结构MRI可见广泛皮质变薄和表面积减小,额颞叶为著。
- 解读患者皮质厚度改变时应考虑抗精神病药物使用、剂量、病程和症状严重程度的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The profile of cortical neuroanatomical abnormalities in schizophrenia is not fully understood, despite hundreds of published structural brain imaging studies. This study presents the first meta-analysis of cortical thickness and surface area abnormalities in schizophrenia conducted by the ENIGMA (Enhancing Neuro Imaging Genetics through Meta Analysis) Schizophrenia Working Group. METHODS: The study included data from 4474 individuals with schizophrenia (mean age, 32.3 years; range, 11-78 years; 66% male) and 5098 healthy volunteers (mean age, 32.8 years; range, 10-87 years; 53% male) assessed with standardized methods at 39 centers worldwide. RESULTS: Compared with healthy volunteers, individuals with schizophrenia have widespread thinner cortex (left/right hemisphere: Cohen's d = -0.530/-0.516) and smaller surface area (left/right hemisphere: Cohen's d = -0.251/-0.254), with the largest effect sizes for both in frontal and temporal lobe regions. Regional group differences in cortical thickness remained significant when statistically controlling for global cortical thickness, suggesting regional specificity. In contrast, effects for cortical surface area appear global. Case-control, negative, cortical thickness effect sizes were two to three times larger in individuals receiving antipsychotic medication relative to unmedicated individuals. Negative correlations between age and bilateral temporal pole thickness were stronger in individuals with schizophrenia than in healthy volunteers. Regional cortical thickness showed significant negative correlations with normalized medication dose, symptom severity, and duration of illness and positive correlations with age at onset. CONCLUSIONS: The findings indicate that the ENIGMA meta-analysis approach can achieve robust findings in clinical neuroscience studies; also, medication effects should be taken into account in future genetic association studies of cortical thickness in schizophrenia.
引用
- van Erp TGM, Walton E, Hibar DP, et al. Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium. Biol Psychiatry. 2018. PMID: 29960671. doi:10.1016/j.biopsych.2018.04.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。